特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
966299

がんワクチンの世界市場:将来予測 (2027年まで)、技術別・種類別・症状別・エンドユーザー別・地域別の分析、新型コロナウイルス感染症 (COVID-19) の影響

Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 179 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
がんワクチンの世界市場:将来予測 (2027年まで)、技術別・種類別・症状別・エンドユーザー別・地域別の分析、新型コロナウイルス感染症 (COVID-19) の影響
出版日: 2020年09月16日
発行: The Insight Partners
ページ情報: 英文 179 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがんワクチンの市場規模は、2019年には45億6882万米ドル、2027年には158億4559万米ドルと、17.2%のCAGRで成長すると予測されています。

当レポートでは、世界のがんワクチンの市場について分析し、市場の基本構造や背景事情 (主な促進・抑制要因など)、市場規模の動向見通し (今後9年間分)、技術別・種類別・症状別・最終用途別・地域別の詳細動向、主要企業のプロファイルと戦略展開状況、昨今の新型コロナウイルス感染症 (COVID-19) に伴う影響、といった情報を取りまとめてお届けいたします。

目次

第1章 イントロダクション

第2章 生検装置市場:分析概要

第3章 分析手法

第4章 がんワクチン市場:市場環境

  • 概要
  • PEST分析
  • 専門家の見解

第5章 世界のがんワクチン市場:市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の動向
  • 市場促進・抑制要因の影響度の分析

第6章 がんワクチン市場:世界市場の分析

  • 市場収益額の予測と分析
  • 市場規模の予測と分析:地域別
  • 主要企業の市場ポジショニング

第7章 がんワクチン市場:技術別

  • 概要
  • がんワクチンの市場シェア:技術別 (2019年、2027年)
  • 樹状細胞がんワクチン
  • 遺伝子組換えがんワクチン
  • 抗原がんワクチン
  • 全細胞がんワクチン
  • ウイルスベクターがんワクチン

第8章 がんワクチン市場:種類別

  • 概要
  • がんワクチンの市場シェア:種類別 (2019年、2027年)
  • 予防用がんワクチン
  • 治療用がんワクチン

第9章 がんワクチン市場:適応症別

  • 概要
  • がんワクチンの市場シェア:適応症別 (2019年、2027年)
  • 子宮頸がん
  • 前立腺がん
  • その他の適応症

第10章 がんワクチン市場:最終用途別

  • 概要
  • がんワクチンの市場シェア:最終用途別 (2019年、2027年)
  • 小児用
  • 成人用

第11章 がんワクチン市場:地域別の分析

  • 北米:がんワクチン市場
  • 欧州:がんワクチン市場
  • アジア太平洋:がんワクチン市場
  • 中東・アフリカ:がんワクチン市場
  • 中南米:がんワクチン市場

第12章 COVID-19感染拡大が世界のがんワクチン市場に与える影響

  • 北米:COVID-19感染拡大の影響度の評価
  • 欧州:COVID-19感染拡大の影響度の評価
  • アジア太平洋:COVID-19感染拡大の影響度の評価
  • 他の国々 (RoW):COVID-19感染拡大の影響度の評価

第13章 がんワクチン市場:業界情勢

  • 概要
  • 各企業が展開した成長戦略
  • 有機的発展
  • 無機的発展

第14章 企業プロファイル

  • CSL Limited
  • ADURO BIOTECH INC.
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc.
  • Dendreon
  • AstraZeneca
  • Merck & Co., Inc.
  • Sanofi (Sanofi Pasteur)
  • OSE Immunotherapeutics

第15章 付録

図表

List Of Tables

  • Table 1. North America Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Estimated Number of New Cancer Cases and Deaths, US, 2020
  • Table 6. US Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 9. US Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 13. Canada Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico Incidence, Mortality and Prevalence by cancer site in 2018
  • Table 15. Mexico Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Mexico Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 18. Mexico Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe Cancer Vaccines Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Europe Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 22. Europe Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
  • Table 24. Germany Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Germany Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Germany Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 27. Germany Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 28. UK Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 29. UK Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 30. UK Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 31. UK Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Incidence, Mortality and Prevalence by cancer site, 2018, France
  • Table 33. France Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 34. France Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 35. France Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 36. France Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Incidence, Mortality and Prevalence by cancer site, 2018, Spain
  • Table 38. Spain Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Spain Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Spain Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 41. Spain Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
  • Table 43. Italy Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Italy Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Italy Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 46. Italy Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Asia Pacific Cancer Vaccines Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 48. Asia Pacific Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Asia Pacific Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 50. Asia Pacific Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 51. China Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 52. China Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 53. China Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 54. China Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Japan Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 56. Japan Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 57. Japan Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 58. Japan Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 59. India Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 60. India Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 61. India Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 62. India Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South Korea Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 64. South Korea Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 65. South Korea Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 66. South Korea Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
  • Table 68. Australia Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Australia Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Australia Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 71. Australia Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Middle East & Africa Cancer Vaccines Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 73. Middle East & Africa Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 74. Middle East & Africa Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 75. Middle East & Africa Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Saudi Arabia Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Saudi Arabia Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Saudi Arabia Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 79. Saudi Arabia Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 80. UAE Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 81. UAE Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 82. UAE Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 83. UAE Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 84. South Africa Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 85. South Africa Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 86. South Africa Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 87. South Africa Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 88. South and Central America Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 89. South and Central America Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 90. South and Central America Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 91. South and Central America Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 92. Brazil Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 93. Brazil Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 94. Brazil Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 95. Brazil Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 96. Argentina Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 97. Argentina Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 98. Argentina Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
  • Table 99. Argentina Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 100. Organic Developments Done By Companies
  • Table 101. Inorganic Developments Done By Companies
  • Table 102. Glossary of Terms, Cancer Vaccines Market

List Of Figures

  • Figure 1. Cancer Vaccines Market Segmentation
  • Figure 2. Cancer Vaccines Market Segmentation, By Region
  • Figure 3. Cancer Vaccines Market Overview
  • Figure 4. Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market
  • Figure 5. APAC to Show Significant Growth During Forecast Period
  • Figure 6. Cancer Vaccines Market, by Geography (US$ Million)
  • Figure 7. Global Cancer Vaccines Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Cancer Vaccines Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Cancer Statistics, 2020
  • Figure 15. Cancer Vaccines Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Cancer Vaccines Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Cancer Vaccines Market
  • Figure 18. Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
  • Figure 19. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
  • Figure 25. Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
  • Figure 28. Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
  • Figure 32. Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. North America: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 35. North America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 36. North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
  • Figure 37. US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Europe: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 41. Europe Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Europe: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
  • Figure 43. Germany: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. UK: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. France: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Spain: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Italy: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Asia Pacific: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 49. Asia Pacific Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 50. China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 56. Middle East & Africa Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Cancer Vaccines Market Share by Country - 2019 & 2027, (%)
  • Figure 58. Saudi Arabia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. UAE: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 60. South Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 62. South and Central America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
  • Figure 64. Brazil: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Argentina: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in Europe Country Markets
  • Figure 68. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in Rest of World Country Markets
  • Figure 70. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00004595

Title:
Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines and Viral Vector Cancer Vaccines), Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer and Other Indications), End User (Pediatrics and Adults) and Geography.

The global cancer vaccines market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; it is estimated to grow at a CAGR of 17.2% from 2020 to 2027.

The growth of the cancer vaccines market is mainly attributed to the globally increasing incidence of cancer and rising number of initiatives related to cancer vaccines by global health research organizations and key companies. However, the commercial availability of a less number of cancer vaccines and higher costs of the same hinder the growth of the market.

Cancer vaccines either assist in the treatment of existing cancers or prevent the development of cancer. Vaccines that enhance body's natural defense capability to fight the existing cancer are as therapeutic cancer vaccines, also known as cancer treatment vaccines. Several vaccines are "autologous"; they are prepared from samples taken from the patients and are specific to that patient. Frequent government initiatives and launches drive the market for cancer vaccines. In December 2019, Cancer Research UK and Vaccitech Oncology Limited announced a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine are intended to induce an attack on cancer cells. The vaccine is likely to deliver cancer-associated antigens (MAGE A3 and NY-ESO-1) to antigen-presenting cells, i.e., dendritic cells, leading to the generation of cytotoxic T-cells by the immune system to attack and destroy the cancer cells expressing the said antigens. Thus, the constant developments in cancer vaccines are expected to accelerate the market growth during the forecast period.

Based on type, the cancer vaccines market is segmented into preventive cancer vaccines and therapeutic cancer vaccines. The preventive cancer vaccines segment held a larger share of the market in 2019, and the same segment is anticipated to register the highest CAGR during the forecast period. Increasing number of cancer patients, growth in geriatric population, rising patient understanding of cancer therapies, development in the use of cancer vaccines in combination with other treatments, and government support to trigger the production are the key factors driving the growth of the market for preventive cancer vaccines. Based on technology, the market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. Based on indication, the market is segmented into cervical cancer, prostate cancer, and other indications. On the basis of end user, the market is segmented into pediatrics and adults.

The World Health Organization (WHO), American Cancer Society, Globocan, Cancer Research UK, Centers for Disease Control and Prevention (CDC), and Clinical and Translational Immunology and Translational Research Institute, along with company websites, are a few of the major primary and secondary sources cited while preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global cancer vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cancer Vaccines Market - By Technology
    • 1.3.2 Global Cancer Vaccines Market - By Type
    • 1.3.3 Global Cancer Vaccines Market - By Indication
    • 1.3.4 Global Cancer Vaccines Market - By End-User
    • 1.3.5 Global Cancer Vaccines market - By Geography

2. Cancer Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cancer Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Cancer Vaccines Market- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increase in Prevalence of Cancer Worldwide
    • 5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
  • 5.2 Key Market Restraints
    • 5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
    • 5.2.2 Higher Cost of Cancer Vaccines
  • 5.3 Key Market Opportunities
    • 5.3.1 Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Growing Research and Development Activities
  • 5.5 Impact analysis

6. Cancer Vaccines Market - Global Analysis

  • 6.1 Global Cancer Vaccines Market Revenue Forecast and Analysis
  • 6.2 Global Cancer Vaccines Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Cancer Vaccines Market - By Technology

  • 7.1 Overview
  • 7.2 Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
  • 7.3 Dendritic Cells Cancer Vaccine
    • 7.3.1 Overview
    • 7.3.2 Dendritic Cells Cancer Vaccines : Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Recombinant Cancer Vaccines
    • 7.5.1 Overview
    • 7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Antigen Cancer Vaccines
    • 7.6.1 Overview
    • 7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Whole Cell Cancer Vaccines
    • 7.7.1 Overview
    • 7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Viral Vector Cancer Vaccines
    • 7.8.1 Overview
    • 7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

8. Cancer Vaccines Market Analysis - By Type

  • 8.1 Overview
  • 8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
  • 8.3 Preventive Cancer Vaccines
    • 8.3.1 Overview
    • 8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Therapeutic Cancer Vaccines
    • 8.4.1 Overview
    • 8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

9. Cancer Vaccines Market Analysis - By Indication

  • 9.1 Overview
  • 9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
  • 9.3 Cervical Cancer
    • 9.3.1 Overview
    • 9.3.2 Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Prostate Cancer
    • 9.4.1 Overview
    • 9.4.2 Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Other Indications
    • 9.5.1 Overview
    • 9.5.2 Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

10. Cancer Vaccines Market Analysis - By End Use

  • 10.1 Overview
  • 10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
  • 10.3 Pediatrics
    • 10.3.1 Overview
    • 10.3.2 Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Adults
    • 10.4.1 Overview
    • 10.4.2 Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

11. Cancer Vaccines Market Analysis And Forecasts To 2027 Geographical Analysis

  • 11.1 North America: Cancer Vaccines Market
    • 11.1.1 Overview
    • 11.1.2 North America: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 11.1.3 North America: Cancer Vaccines Market, by Technology, 2018-2027 (USD Million)
    • 11.1.4 North America: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
    • 11.1.5 North America: Cancer Vaccines Market, by Indication, 2018-2027 (USD Million)
    • 11.1.6 North America: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.1.7 North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
    • 11.1.8 US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.1 US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.2 US: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.1.8.3 US: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.1.8.4 US: Cancer Vaccines Market, by Technology2018-2027 (USD Million)
      • 11.1.8.5 US: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.1.9 Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.1 Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.2 Canada: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.1.9.3 Canada: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.1.9.4 Canada: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.1.9.5 Canada: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.1.10 Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.1 Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.2 Mexico: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.1.10.3 Mexico: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.1.10.4 Mexico: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.1.10.5 Mexico: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
  • 11.2 Europe: Cancer Vaccines Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 11.2.3 Europe: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
    • 11.2.4 Europe: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
    • 11.2.5 Europe: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
    • 11.2.6 Europe: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.2.7 Europe: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
    • 11.2.8 Germany: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.1 Germany: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.2 Germany: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.2.8.3 Germany: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.2.8.4 Germany: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.2.8.5 Germany: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.2.9 UK: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.1 UK: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.2 UK: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.2.9.3 UK: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.2.9.4 UK: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.2.9.5 UK: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.2.10 France: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.1 France: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.2 France: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.2.10.3 France: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.2.10.4 France: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.2.10.5 France: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.2.11 Spain: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.1 Spain: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.2 Spain: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.2.11.3 Spain: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.2.11.4 Spain: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.2.11.5 Spain: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.2.12 Italy: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.1 Italy: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.2 Italy: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.2.12.3 Italy: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.2.12.4 Italy: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.2.12.5 Italy: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
  • 11.3 Asia Pacific: Cancer Vaccines Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 11.3.3 Asia Pacific: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
    • 11.3.4 Asia Pacific: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
    • 11.3.5 Asia Pacific: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
    • 11.3.6 Asia Pacific: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.3.7 Asia Pacific: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
    • 11.3.8 China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.1 China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.2 China: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.3.8.3 China: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.3.8.4 China: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.3.8.5 China: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.3.9 Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.1 Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.2 Japan: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.3.9.3 Japan: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.3.9.4 Japan: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.3.9.5 Japan: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.3.10 India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.1 India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.2 India: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.3.10.3 India: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.3.10.4 India: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.3.10.5 India: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.3.11 South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.1 South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.2 South Korea: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.3.11.3 South Korea: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.3.11.4 South Korea: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.3.11.5 South Korea: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.3.12 Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.1 Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.2 Australia: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.3.12.3 Australia: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.3.12.4 Australia: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.3.12.5 Australia: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
  • 11.4 Middle East & Africa: Cancer Vaccines Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 11.4.3 Middle East & Africa: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
    • 11.4.4 Middle East & Africa: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
    • 11.4.5 Middle East & Africa: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
    • 11.4.6 Middle East & Africa: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.4.7 Middle East & Africa: Cancer Vaccines Market Share by Country - 2019 & 2027, (%)
    • 11.4.8 Saudi Arabia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.1 Saudi Arabia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.2 Saudi Arabia: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.4.8.3 Saudi Arabia: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.4.8.4 Saudi Arabia: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.4.8.5 Saudi Arabia: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.4.9 UAE: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.1 UAE: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.2 UAE: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.4.9.3 UAE: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.4.9.4 UAE: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.4.9.5 UAE: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
    • 11.4.10 South Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
      • 11.4.10.1 South Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.2 South Africa: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
      • 11.4.10.3 South Africa: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
      • 11.4.10.4 South Africa: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
      • 11.4.10.5 South Africa: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
  • 11.5 South and Central America: Cancer Vaccines Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 11.5.3 South and Central America Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 11.5.4 South and Central America Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
    • 11.5.5 South and Central America Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 11.5.6 South and Central America Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.5.7 South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
    • 11.5.8 Brazil: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.1 Brazil: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.2 Brazil Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.3 Brazil Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.4 Brazil Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.5 Brazil Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.5.9 Argentina: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.1 Argentina: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.2 Argentina Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.3 Argentina Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.4 Argentina Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.5 Argentina Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of World: Impact Assessment of COVID-19 Pandemic

13. Cancer Vaccines Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 CSL Limited
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 ADURO BIOTECH INC.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Astellas Pharma Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Bristol-Myers Squibb Company
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 GlaxoSmithKline plc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Dendreon
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 AstraZeneca
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Merck & Co., Inc.
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Sanofi (Sanofi Pasteur)
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 OSE Immunotherapeutics
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.